Katja Seipel - Search Results

Year	Number of Results
2003	1
2004	3
2005	2
2006	2
2014	2
2015	8
2016	7
2017	4
2018	6
2019	2
2020	4
2021	2
2022	0

1

Autologous Transplantation for Older Adults with AML.

Mueller BU, Seipel K, Bacher U, Pabst T. Mueller BU, et al. Among authors: seipel k. Cancers (Basel). 2018 Sep 19;10(9):340. doi: 10.3390/cancers10090340. Cancers (Basel). 2018. PMID: 30235847 Free PMC article. Review.

2

Mesodermal anatomies in cnidarian polyps and medusae.

Seipel K, Schmid V. Seipel K, et al. Int J Dev Biol. 2006;50(7):589-99. doi: 10.1387/ijdb.062150ks. Int J Dev Biol. 2006. PMID: 16892172 Free article. Review.

3

RNA Targeting in Acute Myeloid Leukemia.

Messikommer A, Seipel K, Byrne S, Valk PJM, Pabst T, Luedtke NW. Messikommer A, et al. Among authors: seipel k. ACS Pharmacol Transl Sci. 2020 Oct 12;3(6):1225-1232. doi: 10.1021/acsptsci.0c00120. eCollection 2020 Dec 11. ACS Pharmacol Transl Sci. 2020. PMID: 33344899 Free PMC article.

4

Myelodysplastic syndromes and acute myeloid leukemias in the elderly.

Mueller BU, Seipel K, Pabst T. Mueller BU, et al. Among authors: seipel k. Eur J Intern Med. 2018 Dec;58:28-32. doi: 10.1016/j.ejim.2018.05.026. Eur J Intern Med. 2018. PMID: 30527920 Review.

5

BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK Inhibitor Trametinib in the Treatment of Acute Leukemia.

Seipel K, Kopp B, Bacher U, Pabst T. Seipel K, et al. Cancers (Basel). 2021 Feb 2;13(3):581. doi: 10.3390/cancers13030581. Cancers (Basel). 2021. PMID: 33540760 Free PMC article.

6

Evolution of striated muscle: jellyfish and the origin of triploblasty.

Seipel K, Schmid V. Seipel K, et al. Dev Biol. 2005 Jun 1;282(1):14-26. doi: 10.1016/j.ydbio.2005.03.032. Dev Biol. 2005. PMID: 15936326 Free article. Review.

7

Rationale for a Combination Therapy with the STAT5 Inhibitor AC-4-130 and the MCL1 Inhibitor S63845 in the Treatment of FLT3-Mutated or TET2-Mutated Acute Myeloid Leukemia.

Seipel K, Graber C, Flückiger L, Bacher U, Pabst T. Seipel K, et al. Int J Mol Sci. 2021 Jul 28;22(15):8092. doi: 10.3390/ijms22158092. Int J Mol Sci. 2021. PMID: 34360855 Free PMC article.

8

Inactivation of the p53-KLF4-CEBPA Axis in Acute Myeloid Leukemia.

Seipel K, Marques MT, Bozzini MA, Meinken C, Mueller BU, Pabst T. Seipel K, et al. Clin Cancer Res. 2016 Feb 1;22(3):746-56. doi: 10.1158/1078-0432.CCR-15-1054. Epub 2015 Sep 25. Clin Cancer Res. 2016. PMID: 26408402

9

Analysis of IL-6 serum levels and CAR T cell-specific digital PCR in the context of cytokine release syndrome.

Pabst T, Joncourt R, Shumilov E, Heini A, Wiedemann G, Legros M, Seipel K, Schild C, Jalowiec K, Mansouri Taleghani B, Fux M, Novak U, Porret N, Zeerleder S, Bacher U. Pabst T, et al. Among authors: seipel k. Exp Hematol. 2020 Aug;88:7-14.e3. doi: 10.1016/j.exphem.2020.07.003. Epub 2020 Jul 13. Exp Hematol. 2020. PMID: 32673688 Free article. Clinical Trial.

10

(2R,3S)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia.

Idle JR, Seipel K, Bacher U, Pabst T, Beyoğlu D. Idle JR, et al. Among authors: seipel k. Cancers (Basel). 2020 Oct 1;12(10):2842. doi: 10.3390/cancers12102842. Cancers (Basel). 2020. PMID: 33019704 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results